311 related articles for article (PubMed ID: 26561554)
21. Pharmacologic treatment of opioid-induced constipation.
Wang CZ; Yuan CS
Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
[TBL] [Abstract][Full Text] [Related]
22. Investigational opioid antagonists for treating opioid-induced bowel dysfunction.
Mozaffari S; Nikfar S; Abdollahi M
Expert Opin Investig Drugs; 2018 Mar; 27(3):235-242. PubMed ID: 29266973
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
Ford AC; Brenner DM; Schoenfeld PS
Am J Gastroenterol; 2013 Oct; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
[TBL] [Abstract][Full Text] [Related]
24. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
Jones R; Prommer E; Backstedt D
Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
[TBL] [Abstract][Full Text] [Related]
25. Naloxegol for the treatment of opioid-induced constipation.
Tack J; Corsetti M
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):855-61. PubMed ID: 25220391
[TBL] [Abstract][Full Text] [Related]
26. Opioid-Related Constipation.
Liu JJ; Brenner DM
Gastroenterol Clin North Am; 2022 Mar; 51(1):107-121. PubMed ID: 35135657
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical Outcomes.
Spierings ELH; Drossman DA; Cryer B; Mazen Jamal M; Losch-Beridon T; Mareya SM; Wang M
Pain Med; 2018 Jun; 19(6):1184-1194. PubMed ID: 29016868
[TBL] [Abstract][Full Text] [Related]
28. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.
LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS
J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553
[TBL] [Abstract][Full Text] [Related]
29. The Evolving Role of Long-Term Pharmacotherapy for Opioid-Induced Constipation in Patients Being Treated for Noncancer Pain.
Bowers BL; Crannage AJ
J Pharm Pract; 2019 Oct; 32(5):558-567. PubMed ID: 29207909
[TBL] [Abstract][Full Text] [Related]
30. Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.
Lawson R; King F; Marsh K; Altincatal A; Cimen A
Adv Ther; 2016 Aug; 33(8):1331-46. PubMed ID: 27342744
[TBL] [Abstract][Full Text] [Related]
31. Opioid-induced constipation.
Wein S
J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):382-4. PubMed ID: 23216186
[TBL] [Abstract][Full Text] [Related]
32. Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice.
Fernández-Montes A; de Velasco G; Aguín S; Farriols C; Guirado-Risueño M; Jerviz-Guía VG; Baeza-Nadal MV; Chicas-Sett R; Fírvida JL; García-Navalón F; Martín P; Perezagua-Marín C; Rodríguez D; Santamaría J; Saurí T; Cobo M
Curr Treat Options Oncol; 2021 Feb; 22(3):26. PubMed ID: 33635493
[TBL] [Abstract][Full Text] [Related]
33. Use of Peripheral μ-Opioid Receptor Antagonists for Treating Opioid-Induced Constipation among US Medicare Beneficiaries from 2014 to 2018.
Premnath N; Sumarsono A; Sedhom R; Johnson DH; Subbiah IM; Dy SM; Gupta A
J Palliat Med; 2021 Aug; 24(8):1236-1239. PubMed ID: 33872062
[No Abstract] [Full Text] [Related]
34. Opioid-induced constipation, use of laxatives, and health-related quality of life.
Christensen HN; Olsson U; From J; Breivik H
Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
[TBL] [Abstract][Full Text] [Related]
35. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
Jamal MM; Adams AB; Jansen JP; Webster LR
Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
[TBL] [Abstract][Full Text] [Related]
36. Clinical and Functional Characteristics of Nursing Facility Residents with Opioid-Induced Constipation.
Allen C; Zarowitz BJ; O'Shea T; Datto C; Olufade T
Consult Pharm; 2017 May; 32(5):285-298. PubMed ID: 28483009
[TBL] [Abstract][Full Text] [Related]
37. Management of opioid-induced constipation.
Prichard D; Norton C; Bharucha AE
Br J Nurs; 2016 May 26-Jun 8; 25(10):S4-5, S8-11. PubMed ID: 27231750
[TBL] [Abstract][Full Text] [Related]
38. Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach.
Reimer K; Hopp M; Zenz M; Maier C; Holzer P; Mikus G; Bosse B; Smith K; Buschmann-Kramm C; Leyendecker P
Pharmacology; 2009; 83(1):10-7. PubMed ID: 18957874
[TBL] [Abstract][Full Text] [Related]
39. Methylnaltrexone bromide for the treatment of opioid-induced constipation.
Mozaffari S; Nikfar S; Abdollahi M
Expert Opin Pharmacother; 2018 Jul; 19(10):1127-1135. PubMed ID: 29979903
[TBL] [Abstract][Full Text] [Related]
40. [Opioid-induced constipation in oncologic patient: a clinical case treated with naloxegol].
Gallo P
Recenti Prog Med; 2019 Mar; 110(3):6e-9e. PubMed ID: 30968858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
